IN2013MU03124A - - Google Patents
Info
- Publication number
- IN2013MU03124A IN2013MU03124A IN3124MU2013A IN2013MU03124A IN 2013MU03124 A IN2013MU03124 A IN 2013MU03124A IN 3124MU2013 A IN3124MU2013 A IN 3124MU2013A IN 2013MU03124 A IN2013MU03124 A IN 2013MU03124A
- Authority
- IN
- India
- Prior art keywords
- insulin
- metabolite
- derivative
- isoelectric point
- analogue
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 6
- 239000004026 insulin derivative Substances 0.000 abstract 4
- 102000004877 Insulin Human genes 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 229940125396 insulin Drugs 0.000 abstract 2
- 239000002207 metabolite Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2016107610A RU2016107610A (ru) | 2013-09-30 | 2014-09-29 | Фармацевтическая композиция |
| SG11201601477VA SG11201601477VA (en) | 2013-09-30 | 2014-09-29 | Pharmaceutical composition |
| US15/021,693 US20160271226A1 (en) | 2013-09-30 | 2014-09-29 | Pharmaceutical composition |
| JP2016515453A JP2016531847A (ja) | 2013-09-30 | 2014-09-29 | 医薬組成物 |
| IN3124MU2013 IN2013MU03124A (cs) | 2013-09-30 | 2014-09-29 | |
| EP14799538.5A EP3052114A1 (en) | 2013-09-30 | 2014-09-29 | Pharmaceutical composition |
| AU2014326181A AU2014326181A1 (en) | 2013-09-30 | 2014-09-29 | Pharmaceutical composition |
| PCT/IB2014/064922 WO2015044922A1 (en) | 2013-09-30 | 2014-09-29 | Pharmaceutical composition |
| CN201480053586.6A CN105579052A (zh) | 2013-09-30 | 2014-09-29 | 药物组合物 |
| BR112016006963A BR112016006963A2 (pt) | 2013-09-30 | 2014-09-29 | composição farmacêutica |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3124MU2013 IN2013MU03124A (cs) | 2013-09-30 | 2014-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU03124A true IN2013MU03124A (cs) | 2015-07-31 |
Family
ID=51903957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3124MU2013 IN2013MU03124A (cs) | 2013-09-30 | 2014-09-29 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20160271226A1 (cs) |
| EP (1) | EP3052114A1 (cs) |
| JP (1) | JP2016531847A (cs) |
| CN (1) | CN105579052A (cs) |
| AU (1) | AU2014326181A1 (cs) |
| BR (1) | BR112016006963A2 (cs) |
| IN (1) | IN2013MU03124A (cs) |
| RU (1) | RU2016107610A (cs) |
| SG (1) | SG11201601477VA (cs) |
| WO (1) | WO2015044922A1 (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017145104A1 (en) | 2016-02-25 | 2017-08-31 | Wockhardt Limited | Pharmaceutical composition of insulin glargine and amino acids |
| CN106729639B (zh) * | 2017-01-10 | 2018-02-27 | 鲁南制药集团股份有限公司 | 一种甘精胰岛素注射液及其制备方法 |
| WO2019020820A2 (fr) * | 2017-07-27 | 2019-01-31 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant au moins l'insuline humaine a21g et un suppresseur de glucagon a action prandiale |
| CA3149925A1 (en) * | 2019-08-02 | 2021-02-11 | Case Western Reserve University | Premixed ultra-stable single-chain insulin analogue formulations |
| EP3915571A1 (en) * | 2020-05-29 | 2021-12-01 | Adocia | Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action |
| EP3915572A1 (en) * | 2020-05-29 | 2021-12-01 | Adocia | Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3316363A1 (de) | 1983-05-05 | 1984-11-08 | Deutsche Babcock Anlagen Ag, 4200 Oberhausen | Walzenrost fuer muellverbrennungsanlagen |
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| DK257988D0 (da) | 1988-05-11 | 1988-05-11 | Novo Industri As | Nye peptider |
| JPH04502465A (ja) | 1988-12-23 | 1992-05-07 | ノボ ノルディスク アクティーゼルスカブ | ヒトインシュリン類似物質 |
| IL93282A (en) | 1989-02-09 | 1995-08-31 | Lilly Co Eli | Insulin analogues |
| DK155690D0 (da) | 1990-06-28 | 1990-06-28 | Novo Nordisk As | Nye peptider |
| EP1506003A1 (en) * | 2002-05-07 | 2005-02-16 | Novo Nordisk A/S | Soluble formulations comprising insulin aspart and insulin detemir |
| EP3391876B1 (en) * | 2005-05-23 | 2021-03-10 | SDG, Inc. | Lipid construct for delivery of insulin to a mammal |
| CN101237854B (zh) * | 2005-05-23 | 2013-03-27 | Sdg公司 | 将胰岛素输送到哺乳动物的脂构建体 |
| US8084420B2 (en) | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| US7713929B2 (en) * | 2006-04-12 | 2010-05-11 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| WO2007041481A1 (en) | 2005-09-29 | 2007-04-12 | Biodel, Inc. | Rapid acting and prolonged acting insulin preparations |
| US7718609B2 (en) | 2006-04-12 | 2010-05-18 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| CN101454019A (zh) * | 2006-04-12 | 2009-06-10 | 百达尔公司 | 速效和长效胰岛素联合制剂 |
| ES2558930T3 (es) * | 2007-08-13 | 2016-02-09 | Novo Nordisk A/S | Análogos de la insulina de acción rápida |
| JP2010535842A (ja) | 2007-08-13 | 2010-11-25 | ノボ・ノルデイスク・エー／エス | 速効型インスリンアナログ |
| US20120035103A1 (en) | 2010-01-29 | 2012-02-09 | Pillion Dennis J | Method for administration of insulin and pharmaceutical composition thereof |
| WO2012080320A1 (en) * | 2010-12-14 | 2012-06-21 | Novo Nordisk A/S | Fast-acting insulin in combination with long-acting insulin |
| MX2014001190A (es) | 2011-08-10 | 2014-05-12 | Adocia | Solucion inyectable de al menos insulina basal. |
-
2014
- 2014-09-29 BR BR112016006963A patent/BR112016006963A2/pt not_active Application Discontinuation
- 2014-09-29 EP EP14799538.5A patent/EP3052114A1/en not_active Withdrawn
- 2014-09-29 IN IN3124MU2013 patent/IN2013MU03124A/en unknown
- 2014-09-29 US US15/021,693 patent/US20160271226A1/en not_active Abandoned
- 2014-09-29 CN CN201480053586.6A patent/CN105579052A/zh not_active Withdrawn
- 2014-09-29 JP JP2016515453A patent/JP2016531847A/ja active Pending
- 2014-09-29 WO PCT/IB2014/064922 patent/WO2015044922A1/en not_active Ceased
- 2014-09-29 AU AU2014326181A patent/AU2014326181A1/en not_active Abandoned
- 2014-09-29 SG SG11201601477VA patent/SG11201601477VA/en unknown
- 2014-09-29 RU RU2016107610A patent/RU2016107610A/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201601477VA (en) | 2016-04-28 |
| AU2014326181A1 (en) | 2016-03-17 |
| RU2016107610A (ru) | 2017-11-03 |
| JP2016531847A (ja) | 2016-10-13 |
| WO2015044922A1 (en) | 2015-04-02 |
| BR112016006963A2 (pt) | 2017-08-01 |
| US20160271226A1 (en) | 2016-09-22 |
| CN105579052A (zh) | 2016-05-11 |
| EP3052114A1 (en) | 2016-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015082046A3 (de) | Substituierte oxepine | |
| WO2014194034A3 (en) | Novel metalloproteases | |
| WO2014179629A3 (en) | Compositions and methods | |
| JOP20200175A1 (ar) | حقنة | |
| SG11201506149SA (en) | Polyetheramines based on 1,3-dialcohols | |
| WO2014206561A8 (en) | Novel antibody frameworks | |
| PH12015502382A1 (en) | Pertuzumab variants and evaluation thereof | |
| PH12015502665A1 (en) | Improvements in or relating to organic compounds | |
| IN2013MU03124A (cs) | ||
| ECSDI15014919S (es) | Extension pole mechanism for paint roller | |
| MY176221A (en) | Functionalized polymer composition | |
| Shotton et al. | Beyond the asterisk: Understanding Native American college students. | |
| MX362070B (es) | Polioles que contienen tanino, su producción y su uso. | |
| EP3699250A4 (en) | COMPOSITION PROVIDING A FRESHNESS FEELING CONTAINING A DERIVATIVE OF 2,2,6-TRIMETHYLCYLCYCLOHEXANECARBOXYLIC ACID | |
| EP3063245A4 (en) | Improved materials, treatment compositions,&material laminates, with carbon nanotubes | |
| SG10201401301UA (en) | Conjugated diene based polymer, and polymer composition containing the polymer | |
| SG10201400572VA (en) | Conjugated diene based polymer, and polymer composition containing the polymer | |
| EP2985017A4 (en) | COMPOSITION COMPRISING A 1,2-ALKANE POLYOL | |
| SG10201400571XA (en) | Conjugated diene based polymer, and polymer composition containing the polymer | |
| JP2014189771A5 (cs) | ||
| EP3305267A4 (en) | Fifth generation fu's needle | |
| MX366815B (es) | Polioles, su preparación y su uso. | |
| KR20150079340A (ko) | 자석 볼펜 | |
| Sirikulchayanont | Prof. Somchai whom I respect | |
| Leuckart | Musikalien-Verlags-Katalog FEC Leuckart, Leipzig: alphabetisch-systematisch vollständig bis Ende 1913. |